• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    PDC Unveils New Brand Identity

    MD&M West News: Teamvantage Launches New Parent Company

    BD Receives EUA from FDA for COVID-19, Influenza A/B, RSV Combination Test

    Qosina Names Lee Pochter as Executive Vice President

    FDA Okays Early Feasibility Study for Anteris' TAVR Product
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Deducing the Dual Reality of Elizabeth Holmes

    The Return of the AdvaMed MedTech Conference…Live!

    Material Matters: New Materials Call for New Thinking

    5 Ways to Maintain a Talent-Centric Mindset, Even During Economic Uncertainty

    The Changing Face of UK Medical Device Regulations: Most Recent Update
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Forefront Medical Technology

    Halkey-Roberts Corporation

    Paragon Medical

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Forefront Medical Technology

    Halkey-Roberts Corporation

    Paragon Medical

    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    A Legal Eye’s View of Medtech M&A

    Richard Mattern of Bass, Berry & Sims PLC offers his insights on what can be expected in the M&A space in 2017 and beyond.

    A Legal Eye’s View of Medtech M&A
    Related Content
    • MEDICAL & BIOTECH MANUFACTURING
    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    • Accu-Tube Appoints Matthew Haddle as CEO
    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    • CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Sean Fenske, Editor03.30.17
    Big splashes have been made in recent years with the announcements of major mergers and acquisitions of medical device OEMs. MPO’s own Top 30 company report loses a few list members each year due to these significant transactions (making way for new entries to the list).
     
    Offering his insights on this activity is Richard F. Mattern, a member with Bass, Berry & Sims PLC. Mattern practices in the firm’s Corporate & Securities Practice Group and is based in the firm’s Memphis, Tenn. office. He works within a range of industries, but maintains a particular focus on the medical device space.
     
    Mattern took time to speak with MPO about the latest M&A activity, what he expects in 2017, and what we can look forward to in the years ahead.
     
    Sean Fenske: Can you please briefly explain your role when helping clients with M&A in the medical device industry?


    Richard F. Mattern is a member with Bass, Berry & Sims PLC.
    Richard Mattern: In short, M&A counsel runs the deal. More specifically, M&A counsel is responsible for understanding the client’s strategic objective, building and overseeing a team that can execute on that strategic objective, advising the board on its fiduciary duties, identifying risks through the diligence process, structuring the transaction to maximize benefits and minimize risks, drafting the definitive agreements, closing the transaction, and facilitating a successful integration. Each of these aspects is essential to a successful transaction and shapes nearly every decision made by M&A counsel.
     
    Fenske: We’ve seen some major activity in the M&A space in the medical device industry only to have a comparatively quieter 2016. What do you expect for the remainder of 2017?
    Mattern: For a number of reasons, I would expect 2017 to be a strong year for medical device M&A. First, the integration efforts from the 2015 M&A surge are (or should be) nearly complete. Thus, management will now have the necessary bandwidth to seek out additional opportunities. Second, certain macro-economic factors will spur additional M&A activity. Capital remains relatively accessible as interest rates remain at near historic lows, the IPO market remains choppy, significant cash is sitting on public company balance sheets, and private equity continues to invest in the sector. Similarly, the current political climate will support additional M&A activity. The Trump administration appears committed to scaling back regulation, including the potential repeal of the medical device tax, and lowering corporate tax rates.
     
    Fenske: The one exception in 2016 has been Abbott. Given the challenges they are facing, however, did they possibly move too aggressively with their M&A strategy between their St. Jude and Alere buys?
    Mattern: In 2016, Abbott struck deals with Alere (~$6B) and St. Jude Medical (~$30B). Doing a single deal of that magnitude is significant. Attempting two, especially when you layer on the challenges that came out of these deals—Alere was the subject of a DOJ probe (which has Abbott seeking to terminate the deal) and the allegations St. Jude cardiac devices were vulnerable to a potential cyber security attack—can open oneself up to criticism. However, it is premature to suggest that Abbott was too aggressive. The Abbott-St. Jude combination created a cardiovascular powerhouse, which will fortify their market position, drive revenue growth, and enhance product innovation. Furthermore, whether the Alere deal goes forward and the results of the DOJ probe will significantly shape how we judge Abbott’s 2016.
     
    Fenske: How does a company use M&A as a growth strategy? What are the advantages?
    Mattern: M&A can be an effective growth strategy. The impetus for a majority of M&A deals is generally to expand the product offerings by adding complimentary product lines, plugging holes in the current product offerings, or eliminating the operational or regulatory risks associated with R&D. M&A can also expand the end markets, geographic markets, and distribution channels. In the end, M&A should result in increased revenue at a specific cost and on a relatively short timeline. While growing product offerings, markets, and distribution channels can be accomplished organically, it generally takes more time and comes with a higher risk profile. Thus, M&A is effectively a one-stop solution for growth.
     
    Fenske: Are there special considerations to keep in mind when doing M&A in the medical device industry?
    Mattern: Integration and regulatory considerations are meaningful in medical device M&A. Integration considerations often require solutions for product and distribution channel overlap. Product overlap can result in cannibalization of an otherwise marketable product or may require a disposition of a valuable asset if there are antitrust concerns, each of which dilutes the benefit of the transaction. Distribution channel overlap may require moving from a distributor to a direct model, and/or revising sales territories, which could result in additional integration friction or costs. Generally integration considerations can be managed; however, the regulatory considerations can put the entire deal at risk or significantly alter the value proposition. Antitrust considerations can significantly delay deals and/or require certain assets to be sold (see Zimmer–Biomet deal). FDA considerations include the likelihood of the target’s product being approved and how to appropriately value when that risk exists (see Wright Medica–Biomimetic deal, and a host of pharma deals). Due to the global nature of most large medical device companies, FCPA risk must also be thoroughly vetted, otherwise you may have a significant impediment to consummation of the deal (see Abbott–Alere).
     
    Fenske: Is the window for using M&A for the inversion deal that Medtronic did with Covidien closed with the new regulations that were put into place after that transaction?
    Mattern: Inversion deals (acquiring a foreign company and redomesticating to the target company’s jurisdiction in order to recognize significant tax savings) are not dead, but they are severely wounded. Following the Medtronic–Covidien transaction, the Treasury department issued inversion regulations, which reduced the associated tax benefits and made it more difficult to effectuate. Those regulations effectively killed the AbbVie–Shire deal. Furthermore, the current political climate is very hostile to inversion deals. While on the campaign trail, President Trump labeled the Pfizer–Allergan deal and the related loss of jobs as “disgusting.” Secretary Clinton and Senator Sanders similarly blasted the deal. Thus, in the short-term, companies will be unlikely to utilize an inversion structure due to the loss of tax benefits and the likelihood of a very public reprisal.
     
    Fenske: What do you see in terms of non-traditional companies (e.g., tech companies) making acquisitions of medical device firms? Is that something you expect or will they simply continue to partner?
    Mattern: In 2016, there were several deals between tech companies and medical device or healthcare companies, including the Apple–Gliimpse, Nokia–Withings, and Logitech–Jaybird deals. Despite those deals, I think the vast majority of deals will continue to be partnerships or license arrangements. The cultural and operational differences between the sectors make those deals difficult to consummate. In contrast, licenses and partnerships tend to side-step those issues.
     
    Fenske: Where are we headed with regard to medtech M&A? What’s on the horizon in the next five to ten years?
    Mattern: I would expect continued consolidation. The fundamental drivers—access to capital, the ability to use M&A to expand the product offerings/extension of R&D without (or minimizing) the associated regulatory approval risk, and a generally supportive political environment—remain prevalent. However, I expect the pace to slow. Inversion deals, which fueled some of the prior M&A, won’t be a significant factor in the near term for reasons offered earlier. Furthermore, due to the prior consolidation, you have both a smaller pool of targets and, as a result, increased antitrust risk.
    Related Searches
    • mpo-mag
    • sales
    • medical
    • legal
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    CE Mark Granted to Predictive Software for Kidney Allograft Survival CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    Molli Surgical Molli Surgical's Breast Tumor Marker
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    RapidPulse Closes $15 Million Series A Financing RapidPulse Closes $15 Million Series A Financing
    Midwest Products & Engineering Acquires MindFlow Design Midwest Products & Engineering Acquires MindFlow Design
    Vicarious Surgical Opens New Corporate Headquarters in Massachusetts Vicarious Surgical Opens New Corporate Headquarters in Massachusetts
    Luis J. Malavé Joins Integrity Applications Board Luis J. Malavé Joins Integrity Applications Board

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21

    • Tubing & Extrusion
      Accu-Tube Appoints Matthew Haddle as CEO

      Accu-Tube Appoints Matthew Haddle as CEO

      Haddle has a track record of leading organizations through strategic expansions across the medical device, aerospace, and industrial sectors.
      Accu-Tube 09.22.21


    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    • CE Mark Granted to Predictive Software for Kidney Allograft Survival

      CE Mark Granted to Predictive Software for Kidney Allograft Survival

      Algorithm gives the probability the graft will still be functional at three, five, and seven years after evaluation by a healthcare professional.
      Cibiltech 09.21.21

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • MO SCI Acquires Assets Of 3M’s Advanced Materials Business
    • CGM Devices Could Become Main Glucose Monitoring Solution In U.S.
    • Endologix Shares Positive 12-Month Results Of DETOUR-2 Trial
    • FDA Okays Early Feasibility Study For Anteris' TAVR Product
    Breaking News
    • PDC Unveils New Brand Identity
    • MD&M West News: Teamvantage Launches New Parent Company
    • BD Receives EUA from FDA for COVID-19, Influenza A/B, RSV Combination Test
    • Qosina Names Lee Pochter as Executive Vice President
    • FDA Okays Early Feasibility Study for Anteris' TAVR Product
    View Breaking News >
    CURRENT ISSUE

    January/February 2023

    • Struggling Suppliers in Electronics Manufacturing Services (EMS)
    • Machining & Laser Processing Have Huge Parts to Play
    • Medtech R&D Teams Must Be Creative & Resilient to Survive
    • Medtronic Neuromodulation President, Nnamdi Njoku, Interview
    • 6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Tocotrienols May Have Protective Effect on Liver in NAFLD Patients
    Indian Gooseberry Extract Shown to Offer Blood Sugar Management Benefits
    ADM Expands Production to Meet Demand for Probiotics
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel Reports Revenue Growth in 2022
    Orion Engineered Carbons Announces New Distribution Partnerships
    Personnel Changes at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    PDC Unveils New Brand Identity
    MD&M West News: Teamvantage Launches New Parent Company
    BD Receives EUA from FDA for COVID-19, Influenza A/B, RSV Combination Test
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Gerresheimer/Corning Announce Joint Venture to Meet Growing Demand for Velocity Vials
    KORSCH Acquires MEDELPHARM to Strengthen R&D Product Line
    SRI Names Kathlynn Brown Biosciences Division President
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Kiss Colors & Care Taps Rapper JT as Brand Partner
    Revolution Beauty Expands into Walmart in the U.S.
    Macro-Environmental Factors Impacting the Packaging Industry
    Happi

    Latest Breaking News From Happi

    Perfect Corp. Receives MLPS 2.0-Compliant Status to Help Beauty Brands Meet China's National Cybersecurity Standards
    Mary Kay Supports Ocean Conservation at International Marine Protected Area Congress
    Mintel Reveals Macro-Environmental Factors Impacting Household and Personal Care Packaging
    Ink World

    Latest Breaking News From Ink World

    Heidelberg Well on Track after Three Quarters of FY2022/23
    Orion Carbons Announces New Distribution Partnerships
    DuPont Reports 4Q, Full Year 2022 Results
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    'Build Back the Wisconsin Paper Industry' event announced
    Magic Johnson to keynote Dscoop Edge St. Louis World Expo
    Norway's Digital Etikett grows with HP Indigo
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Edgewell’s Sales Increase
    Mitsui Chemicals, Asahi Kasei Combine Nonwovens Businesses
    Hospeco Offers TaskBrand Prep-Paint-Finish Wiping System
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OssDsign Launches New Product for Additional Surgical Procedures
    OSSIO Introduces Non-Permanent Compression Staple
    Dennis Jones Joins Intelivation Technologies as Manufacturing VP
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Partners with Fundación Cardiovascular de Colombia
    Emerson Reports 1Q 2023 Results
    Identiv Expands NFC and HF Solutions Portfolio

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login